View in EDS HTML Full Text PDF Full Text

Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.

Saved in:
Bibliographic Details
Title: Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.
Authors: Kheraldine, Hadeel1,2 (AUTHOR), Gupta, Ishita1,3 (AUTHOR), Cyprian, Farhan Sachal1,2 (AUTHOR), Vranic, Semir1 (AUTHOR), Al-Farsi, Halema F.1 (AUTHOR), Merhi, Maysaloun4,5 (AUTHOR), Dermime, Said4,5 (AUTHOR), Al Moustafa, Ala-Eddin1,2,6 (AUTHOR) aalmoustafa@qu.edu.qa
Source: Cancer Cell International. 3/2/2024, Vol. 24 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752867
DOI:10.1186/s12935-023-03195-z